Remove companies h-r-block-inc
article thumbnail

Judge Stops H&R Block Rival From Using 'Block' Name

IP Law 360

A Missouri federal judge has barred the fintech company Block Inc. from using its name in connection with a tax service offering it operates, handing a win to H&R Block in its trademark lawsuit.

article thumbnail

8th Circ. Reverses 'Block' Bar On H&R Block Rival

IP Law 360

The Eighth Circuit undid a temporary bar on Block Inc. from using its name in connection with its tax product, finding Tuesday that a lower court incorrectly concluded that an injunction was warranted because consumers could confuse the company's product with H&R Block's filing services.

40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Quick Links from the Past Year, Part 3 (Trademarks)

Technology & Marketing Law Blog

Platinum Properties Investor Network, Inc. H&R Block, Inc. Block, Inc., April 28, 2022): “That confusion has been amplified by Block’s public communications and worsened by third parties who have, and will likely continue, to link Block, Inc. HomeAdvisor, Inc.,

article thumbnail

Copyright Roundup, November 2021

Velocity of Content

The company said it had been working with the Alliance since October 2019, when France introduced a copyright[?adjacent] In April 2020, Senators Leahy (D-VT) and Tillis (R-NC) wrote to the Copyright Office and (in the context of the Supreme Court’s then-recent decision in Allen v. H&M Hennes & Mauritz, LP.

article thumbnail

Recent Hot Topics and Developments in Trade Secrets Law

Trading Secrets

In the case, a pharmaceutical company sued a former product development employee and his new employer in the District of New Jersey for misappropriation of trade secrets in violation of the DTSA. Similarly, in Five Star Gourmet Foods, Inc. Fresh Express, Inc. at *8; see also Payward, Inc. Contractors Inc.

Law 59
article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

Several other companies have also announced plans to pursue interchangeable status for biosimilar products. Consistent with this, as shown below in Table 2, numerous companies have publicly announced the submission and/or acceptance of new biosimilar BLAs. Stimufend ® (Fresenius Kabi). Neulasta ® (Amgen). pegfilgrastim.